Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Capital Expenditures (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Capital Expenditures for 5 consecutive years, with $8000.0 as the latest value for Q1 2025.

  • For Q1 2025, Capital Expenditures changed N/A year-over-year to $8000.0; the TTM value through Dec 2025 reached $8000.0, down 72.41%, while the annual FY2025 figure was $8000.0, 72.41% down from the prior year.
  • Capital Expenditures hit $8000.0 in Q1 2025 for Kezar Life Sciences, down from $11000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.2 million in Q1 2023 and bottomed at -$476000.0 in Q3 2022.
  • Average Capital Expenditures over 5 years is $166857.1, with a median of $26000.0 recorded in 2021.
  • Year-over-year, Capital Expenditures tumbled 1500.0% in 2022 and then surged 1000.0% in 2024.
  • Kezar Life Sciences' Capital Expenditures stood at $392000.0 in 2021, then tumbled by 108.67% to -$34000.0 in 2022, then soared by 102.94% to $1000.0 in 2023, then soared by 1000.0% to $11000.0 in 2024, then dropped by 27.27% to $8000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $8000.0, $11000.0, and $18000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.